Patrick D. Yeramian, Chief Medical Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 2,812 shares at $16.33 ($46K) on 2024-01-09, disclosed to the SEC on 2024-01-11.
Open-market sale of $46k AMLX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AMLX | SELL | 2023-03-24 | $3.5M | — | Filing → |
| AMLX | SELL | 2023-01-10 | $74K | — | Filing → |